Target intelligence / Profile preview

OFD1 pseudogene 16 Y-linked (OFD1P16Y)

Target
OFD1P16Y
Molecular classification
Other (Pseudogene)
01

Overview

OFD1 pseudogene 16 Y-linked (OFD1P16Y) is a member of the OFD1 gene family located on the Y chromosome. Unlike its coding relatives (such as OFD1X and OFD1Y, which have clear roles in development and disease), OFD1P16Y is classified as a pseudogene, meaning it resembles a functional gene but has lost its coding potential due to mutations or truncations. It does not produce a functional protein and, to current knowledge, has no direct involvement in biological processes or disease. Its presence is mainly the result of evolutionary retroposition and duplication events affecting the OFD1 gene family[1][2]. **Additional context:** - The canonical, disease-relevant targets in the OFD1 gene family are **OFD1 (oral-facial-digital syndrome 1) protein** and its variants/mutations on the X chromosome (OFD1X) and sometimes on the Y chromosome (OFD1Y), which play well-documented roles in ciliary function, microtubule dynamics, and several syndromes[2][3]. - Pseudogenes like OFD1P16Y are common byproducts of gene duplication and retroposition. They usually lack exons required for splicing, transcription, and translation, thus they neither encode functional proteins nor participate in regulatory networks, except rarely in non-coding RNA functions[1][2]. There is no evidence that OFD1P16Y is a valid drug target or that it directly participates in human health or disease[1][2]. This makes the designation of OFD1P16Y as a therapeutic target incorrect for structured drug discovery or molecular medicine purposes.

Other names
OFD1P16OFD1PY16OFDYP16
02

Biological functions

Other (Pseudogenes generally have no known biological function; in rare cases, they may serve as transcripts or affect regulation, but this is unproven for OFD1P16Y[1][2].)
03

Disease associations

Other (No direct disease connection; the functional OFD1 gene, not its pseudogenes, is implicated in syndromes such as oral-facial-digital syndrome, SGBS2, and Joubert syndrome[2][3].)
04

Safety considerations

None recorded.
05

Interacting drugs

None known. Pseudogenes are not drug targets.
06

Biomarkers

None known.

Beyond the preview

Go deeper on OFD1 pseudogene 16 Y-linked (OFD1P16Y).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OFD1 pseudogene 16 Y-linked (OFD1P16Y).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call